Taiwan FDA registration 51cda4c091b68ad6c6e7e6a8b65cc984

"Kabi" white blood cell filter for red blood cell concentrate (with sterile air filter)

TW: “卡比” 紅血球濃縮液專用白血球過濾器(含無菌空氣濾膜)
Taiwan flagTaiwan·Risk Class 2·Fresenius Kabi AG; FRESENIUS HEMOCARE ITALIA S.R.L.·Registered Sep 09, 2016 – Sep 09, 2021Cancelled
Registration details
Analysis ID
51cda4c091b68ad6c6e7e6a8b65cc984
Customs Code
DHA05602848503
Company information
Manufacturer Country
Italy;;Germany
Authorized Representative
FRESENIUS KABI TAIWAN LIMITED
Product details
Intended Use
Remove white blood cells from the red blood cell concentrate.
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.9100 Containers for the collection and disposal of blood and blood components
Import Information
Input;; Contract manufacturing
Dates and status
Registration Date
Sep 09, 2016
Expiry Date
Sep 09, 2021
Cancellation Date
Aug 28, 2023
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Kabi" white blood cell filter for red blood cell concentrate (with sterile air filter) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 51cda4c091b68ad6c6e7e6a8b65cc984 and manufactured by Fresenius Kabi AG; FRESENIUS HEMOCARE ITALIA S.R.L.. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices